Select Page
COVID-19

Was it a COVID-19 Vaccine Gamble in Children?

High-risk individuals prioritized for full vaccination and boosters every 6-12 months. • 2:13 Medium priority group includes healthy adults under 50-60 for primary series and first booster. • 2:34 Low priority group consists of healthy children and adolescents up to...

Was Pfizer being Evasive with its Latest Press Release?

The timing of the press release raised questions about burying bad news and lack of transparency. • 0:00 The opening of European markets for PAX loid was highlighted, providing greater access to the Coronavirus protease inhibitor. • 0:00 The press release was issued...

Was the General Public a Willing Participant in Covid Discrimination?

Majority followed measures due to lack of unbiased information and trust in institutions. • 4:50 Public succumbed to measures out of fear and questionable trust in institutions. • 6:50 Government's deliberate use of psychology tactics manipulated public perception and...

What are vaccine Regulatory Protocols outside a COVID-19 Pandemic? With Susan F. Langlois.

Susan Langlois started her career in 1972 as a lab technologist at Cana Laboratories. • 2:50 Langlois' expertise spans from biologicals to medical devices in the pharmaceutical industry. • 3:10 She transitioned to regulatory affairs in 1976, overseeing compliance with...

What can we learn about COVID-19 from the vaccine hesitant Amish?

Amish community faced COVID-19 without vaccines, emphasizing virtues over mainstream practices. • 0:14 Unique approach of Amish community led to high COVID-19 transmission rates. • 2:09 Excess deaths remained elevated among Amish and Mennonite communities post...

What happens when Levels of IgG4 (tolerant antibody) Falls?

Dr. Philip McMillan discusses the significance of IgG4 levels in immunity post-vaccination. • 0:03 Antibody levels post-infection typically average around 300 nanog per mil. • 1:58 Concerns raised about significant rise in IgG4 levels post-vaccination. • 2:26 IgG4, an...
Is Disease-X just COVID-19 (JN.1) Rebranded?

Is Disease-X just COVID-19 (JN.1) Rebranded?

Discussion on Disease X and its potential similarities to COVID-19 • 0:00 Importance of analyzing the outcomes and decisions made during the COVID-19 pandemic • 2:54 Concerns about the new variant and its impact in the upcoming months • 3:28 Importance of preparing...